Variant report
Variant | esv3483814 |
---|---|
Chromosome Location | chr9:98336970-98337302 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:98335123..98337480-chr9:98341108..98343369,3 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs59999956 | chr9:98336970-98336971 | Enhancers Weak transcription Bivalent Enhancer Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs533971860 | chr9:98336975-98336976 | Enhancers Weak transcription Bivalent Enhancer Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs112412041 | chr9:98336993-98336994 | Enhancers Weak transcription Bivalent Enhancer Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs376717324 | chr9:98336995-98336996 | Enhancers Weak transcription Bivalent Enhancer Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs542305364 | chr9:98337015-98337016 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs112932340 | chr9:98337016-98337017 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563776908 | chr9:98337055-98337056 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546174723 | chr9:98337077-98337078 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575591486 | chr9:98337091-98337092 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs13293092 | chr9:98337115-98337116 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs564787577 | chr9:98337125-98337126 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs369227277 | chr9:98337126-98337127 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs373223056 | chr9:98337130-98337131 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs528810620 | chr9:98337146-98337147 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs377052457 | chr9:98337154-98337155 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs190263483 | chr9:98337165-98337166 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs78531500 | chr9:98337166-98337167 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs201945481 | chr9:98337194-98337195 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs200677969 | chr9:98337200-98337201 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs373818493 | chr9:98337216-98337217 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs561911968 | chr9:98337229-98337230 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529453937 | chr9:98337301-98337302 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Biliary cancer | 19435499 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Breast cancer | 17133270 | CNVD |
Basal cell nevus syndrome | 21572526 | CNVD |
Mental retardation | 19951919 | CNVD |
Retinoblastoma | 22278416 | CNVD |
9q22.3 microdeletion syndrome | 22283845 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
overgrowth syndrome | 16570072 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:98332600-98350000 | Weak transcription | Right Atrium | heart |
2 | chr9:98333800-98337400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr9:98335000-98338000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr9:98336400-98337000 | Active TSS | A549 | lung |
5 | chr9:98336400-98338000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr9:98336600-98337200 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
7 | chr9:98337000-98337400 | Flanking Active TSS | A549 | lung |
8 | chr9:98337000-98337600 | Bivalent Enhancer | Placenta | Placenta |